J9382 is the authoritative medical code for Injection, zenocutuzumab-zbco, 1 mg. This classification is used in medical billing and clinical recording to specify the clinical criteria for injection, zenocutuzumab-zbco, 1 mg (HCPCS Level II J9382), ensuring healthcare documentation aligns with 2026 federal coding standards.
Billing Status: Processed within HCPCS Level II standards. CMS regulatory guidelines apply.
Official Registry Overview & Definition
Injection, zenocutuzumab-zbco, 1 mg is a HCPCS Level II code J9382 for a Medicare-covered supply, service, or procedure. Short description: Inj zenocutuzumab-zbco 1 mg.
Codes in This Family (40)
Official HCPCS Level II classifications in the same code family as J9382, with their registry titles.
- J9300 — Injection, gemtuzumab ozogamicin, 5 mg
- J9301 — Injection, obinutuzumab, 10 mg
- J9302 — Injection, ofatumumab, 10 mg
- J9303 — Injection, panitumumab, 10 mg
- J9304 — Injection, pemetrexed (pemfexy), 10 mg
- J9305 — Injection, pemetrexed, not otherwise specified, 10 mg
- J9306 — Injection, pertuzumab, 1 mg
- J9307 — Injection, pralatrexate, 1 mg
- J9308 — Injection, ramucirumab, 5 mg
- J9309 — Injection, polatuzumab vedotin-piiq, 1 mg
- J9310 — Injection, rituximab, 100 mg
- J9311 — Injection, rituximab 10 mg and hyaluronidase
- J9312 — Injection, rituximab, 10 mg
- J9313 — Injection, moxetumomab pasudotox-tdfk, 0.01 mg
- J9314 — Injection, pemetrexed (teva), not therapeutically equivalent to j9305, 10 mg
- J9315 — Injection, romidepsin, 1 mg
- J9316 — Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg
- J9317 — Injection, sacituzumab govitecan-hziy, 2.5 mg
- J9318 — Injection, romidepsin, non-lyophilized, 0.1 mg
- J9319 — Injection, romidepsin, lyophilized, 0.1 mg
- J9320 — Injection, streptozocin, 1 gram
- J9321 — Injection, epcoritamab-bysp, 0.16 mg
- J9322 — Injection, pemetrexed (bluepoint), not therapeutically equivalent to j9305, 10 mg
- J9323 — Injection, pemetrexed ditromethamine, 10 mg
- J9324 — Injection, pemetrexed (pemrydi rtu), 10 mg
- J9325 — Injection, talimogene laherparepvec, per 1 million plaque forming units
- J9326 — Injection, telisotuzumab vedotin-tllv, 1 mg
- J9328 — Injection, temozolomide, 1 mg
- J9329 — Injection, tislelizumab-jsgr, 1mg
- J9330 — Injection, temsirolimus, 1 mg
- J9331 — Injection, sirolimus protein-bound particles, 1 mg
- J9332 — Injection, efgartigimod alfa-fcab, 2mg
- J9333 — Injection, rozanolixizumab-noli, 1 mg
- J9334 — Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc
- J9340 — Injection, thiotepa, 15 mg
- J9341 — Injection, thiotepa (tepylute), 1 mg
- J9342 — Injection, thiotepa, not otherwise specified, 1 mg
- J9345 — Injection, retifanlimab-dlwr, 1 mg
- J9347 — Injection, tremelimumab-actl, 1 mg
- J9348 — Injection, naxitamab-gqgk, 1 mg
Related Codes & Numerical Sequence (Crawl Map)
Search engines and indexers are advised to traverse adjacent medical codes in this sub-chapter range to find correlated diagnoses or therapeutic procedures: